Zealand Pharma A/S ADR (ZEAL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 2,274 | 8,251 | 16,876 | 13,669 | 7,752 |
| Cost of Goods | 439 | 3,641 | 4,559 | 5,109 | 3,849 |
| Gross Profit | 1,835 | 4,598 | 12,329 | 8,560 | 3,903 |
| Operating Expenses | 47,815 | 49,803 | 46,468 | 55,665 | 47,043 |
| Operating Income | -45,541 | -44,552 | -33,592 | -46,996 | -42,292 |
| Interest Expense | 3,087 | -660 | 393 | 2,333 | 446 |
| Other Income | 23,149 | -47 | 2,942 | 0 | 3,662 |
| Pre-tax Income | -25,480 | -43,939 | -31,043 | -49,328 | -39,076 |
| Income Tax | -1,821 | -866 | 500 | -1,215 | 182 |
| Net Income Continuous | -23,659 | -43,072 | -31,544 | -48,114 | -39,258 |
| Net Income | $-23,659 | $-43,072 | $-31,544 | $-48,114 | $-39,258 |
| EPS Basic Total Ops | -0.78 | -1.00 | -0.73 | -1.11 | -0.94 |
| EPS Basic Continuous Ops | -0.55 | -1.00 | -0.72 | -1.11 | -0.94 |
| EPS Diluted Total Ops | -0.78 | -1.00 | -0.73 | -1.11 | -0.94 |
| EPS Diluted Continuous Ops | -0.55 | -1.00 | -0.73 | -1.11 | -0.94 |
| EPS Diluted Before Non-Recurring Items | -0.63 | -1.00 | -0.73 | -1.11 | -0.94 |
| EBITDA(a) | $-45,541 | $-44,552 | $-33,592 | $-46,996 | $-42,292 |